Artemether/Lemefantrine
Edina Avdic, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients with ≥ 5 kg.
- Manufacturer does not recommend use for the treatment of severe malaria or the prevention of P. falciparum malaria.
- Most recent CDC guidelines recommend artemether/lumefantrine use for the treatment of severe malaria following administration of IV artesunate or while waiting for IV artesunate to arrive from CDC (see CDC website)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of severe malaria due to P. falciparum following administration of IV artesunate or while awaiting for IV artesunate to arrive from CDC.
- Treatment of uncomplicated P. vivax malaria (2015 WHO recommendations)[2].
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved